chr1-6424991-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_031475.3(ESPN):c.36G>T(p.Gln12His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000212 in 1,460,618 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_031475.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ESPN | NM_031475.3 | c.36G>T | p.Gln12His | missense_variant | 1/13 | ENST00000645284.1 | NP_113663.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ESPN | ENST00000645284.1 | c.36G>T | p.Gln12His | missense_variant | 1/13 | NM_031475.3 | ENSP00000496593.1 | |||
ESPN | ENST00000636330.1 | c.36G>T | p.Gln12His | missense_variant | 1/11 | 5 | ENSP00000490186.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 151868Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000132 AC: 1AN: 75948Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 43780
GnomAD4 exome AF: 0.0000115 AC: 15AN: 1308750Hom.: 0 Cov.: 31 AF XY: 0.00000775 AC XY: 5AN XY: 645206
GnomAD4 genome AF: 0.000105 AC: 16AN: 151868Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74190
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 20, 2022 | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 1213573). This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 12 of the ESPN protein (p.Gln12His). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ESPN-related conditions. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 16, 2020 | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2023 | The c.36G>T (p.Q12H) alteration is located in exon 1 (coding exon 1) of the ESPN gene. This alteration results from a G to T substitution at nucleotide position 36, causing the glutamine (Q) at amino acid position 12 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at